Page 1577 - Clinical Small Animal Internal Medicine
P. 1577

171  Skeletal Development and Homeostasis  1515

               Figure 171.1  Molecular control of osteoclast   Monocyte
  VetBooks.ir  M‐CSF and RANKL fuse to form multinucleate
                                                         precursors
               differentiation. Monocytes stimulated by
               osteoclasts. Interruption of the RANK‐RANKL
               axis offers a therapeutic approach to disease
               characterized by increased osteoclastic
               activity. Source: Reproduced with permission
               from Allen MJ. Cellular and molecular biology.        RANK expressed
               In: Damron T, ed. Oncology and Basic Science          on monocytes
               (Orthopaedic Surgery Essentials). Baltimore,                            Fusion into
                                                                                       osteoclasts
               MD: Lippincott, Williams and Wilkins, 2007.

                                                                                                         Osteoclast
                                                            RANKL
                                                                                  OPG


                                                                  Osteoblast
                                                                 (or stromal cell)

               multinucleate osteoclast. Increases in the ratio of   and replace damaged bone (leading to bone fragility
               RANKL to OPG favor net bone loss, while decreases     secondary to bone fatigue failure).
               favor net bone accrual.                             Since net bone mass is sensitive to changes in both
                 A number of drug therapies have now been developed     formation and resorption, attention has also been paid to
               for modulating  osteoclastic  activity. The most  widely   the role of anabolic factors that modulate skeletal activ-
               used antiresorptive agents are bisphosphonates such as   ity. In the context of long bone growth, it has been shown
               pamidronate, clodronate, alendronate, and zoledronate.   that growth hormone is capable of enhancing longitudi-
               These compounds, which bind to mineral within the   nal bone growth in the immature skeleton. In the adult
               bone matrix, are released when mineral is resorbed by   animal, preclinical studies have confirmed the anabolic
               osteoclastic activity. Direct exposure of the osteoclast to   potential of both exogenous parathyroid hormone (PTH)
               high levels of these drugs leads to osteoclast apoptosis   and bone morphogenetic proteins (BMPs). Intermittent
               and  a  decrease  in  bone  resorptive  activity.  Although   (daily) treatment with recombinant or synthetic forms of
                 initially introduced for osteoporosis, bisphosphonates   human PTH is effective in enhancing overall bone mass
               are now widely used in the management of patients with   and accelerating bone repair after fracture. Bone mor-
               other  forms of  pathologic bone  resorption,  including   phogenetic proteins, including BMP‐2 and BMP‐7, have
               hypercalcemia of malignancy (e.g., with anal sac adeno-  been studied extensively in dogs and BMP‐2 is now avail-
               carcinoma), primary bone cancer (e.g., osteosarcoma,   able commercially as a potential treatment to accelerate
               feline oral squamous cell carcinoma) or secondary   or enhance fracture healing.
               bone  metastases (e.g., from mammary or  prostatic
               carcinoma).                                        Effects of Mechanical Loading on Bone
                 An alternative approach to controlling osteoclastic
               activity involves targeting the RANK‐RANKL pathway   Julius Wolff (1836–1902) was a German surgeon who
               by administration of exogenous OPG or RANK‐Fc      first identified the relationship between mechanical
                 antibodies that serve as competitive antagonists for the   forces and bone structure. He likened the arrangement
               RANK receptor.                                     of trabecular bone in the neck of the femur to the
                 Decreases in normal bone resorptive activity are also   arrangement of supports in a crane, with the trabeculae
               not without consequence. The most extreme example of   being oriented to best resist the forces to which the
               this can be seen in patients with osteopetrosis, a con-    femoral  neck was being  exposed.  Although  originally
               genital disease in which there is failure of osteoclast for-  published in German in 1892, Wolff’s law can be sum-
               mation or functionality. The classic clinical features of   marized thus: “Bone changes its structure according to
               bone fragility, osteoarthritis, and marrow failure can all   the mechanical loads to which it is exposed.”
               be explained by failures of osteoclastic resorption,   Once the adult skeleton has formed, it continues to
               including an inability to remodel and expand the medul-  adapt to the prevailing mechanical environment. Graphic
               lary canal (and an absence of space for hematopoiesis),   evidence of the importance of mechanical loading
               failure to remodel cortical and trabecular bone (leading   in  driving the change in bone shape and bone mass
               to increased bone mineral density) and failure to resorb   (bone modeling) comes from professional tennis players
   1572   1573   1574   1575   1576   1577   1578   1579   1580   1581   1582